4th Quarter - Report

AVENUE SOLUTIONS for GENENTECH USA, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to Medicare Part B, CMS coverage and reimbursement, 340b drug pricing program; S. 773, A bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes; S. 3799, PREVENT Pandemics Act; S. 3700/H.R. 6833, Affordable Insulin Now Act; Issues related to reauthorization of FDA user fee bills (H.R.7667, Food and Drug Amendments of 2022; S.4348 Food and Drug Administration Safety and Landmark Advancements Act of 2022 (FDSLA Act of 2022)), including accelerated approval and reimportation; Issues related to the Public Health Emergency; Issues related to the White House Cancer Moonshot initiative; Issues related to accelerated approval; Issues related to patient assistance programs and copay accumulators; Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act; Executive Order Directing HHS to Explore Additional Actions to Lower Prescription Drug Costs

LobbyistCovered position, as disclosed
ELIZABETH MACDONALD BARNETT —
TRACY SPICER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 7667 (117th), H.R. 6833 (117th), S. 773 (117th), S. 3799 (117th), S. 3700 (117th), S. 4348 (117th)

Medicare/Medicaid MMM

Inflation Reduction Act of 2022 (PL 117-169) - creating Medicare negotiation of drugs, creating a new inflation rebate under Medicare, limiting insulin copays to $35/month, capping Medicare Part D premium growth, expanding premium and co-pay assistance on prescription drugs for low-income individuals, and capping Medicare out of pocket costs at $2,000 per year, and preventing commercial spillover of maximum fair price into markets beyond Medicare; Issues related to Continuing Resolution, H.R. 6833; Issues related to Medicare Part B, CMS coverage and reimbursement, 340b drug pricing program;

LobbyistCovered position, as disclosed
ELIZABETH MACDONALD BARNETT —
TRACY SPICER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 6833 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.